Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgery Partners CS (NQ: SGRY )

25.32 -1.31 (-4.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Surgery Partners CS

< Previous 1 2 3 Next >
Tenet Healthcare Stock Trying To Close In On Key Technical Benchmark
A Relative Strength Rating upgrade for Tenet Healthcare shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Surgery Partners Stock Gets Technical Rating Upgrade
In a welcome move, Surgery Partners stock saw its Relative Strength Rating improve from 65 to 77 on Tuesday. 
Via Investor's Business Daily
Analyst Expectations for Surgery Partners's Future
Via Benzinga
Surgery Partners's Return On Capital Employed Overview
Via Benzinga
Where Surgery Partners Stands With Analysts
Via Benzinga
Why Surgery Partners Stock Is Falling 8% Today
Surgery Partners Inc (NASDAQ: SGRY) shares are trading lower by 8.06% to $25.09 after the company announced a $275M common stock offering. What Else? 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Recap: Surgery Partners Q2 Earnings
  Surgery Partners (NASDAQ:SGRY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Analyst Ratings for Surgery Partners
Analysts have provided the following ratings for Surgery Partners (NASDAQ:SGRY) within the last quarter: 
Via Benzinga
Recap: Surgery Partners Q1 Earnings
Surgery Partners (NASDAQ:SGRY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
Amazon, Apple, Tesla And Other Big Gainers From Thursday
U.S. stocks closed higher on Thursday, with the Dow Jones jumping more than 1,200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
D.R. Horton To $84? Plus This Analyst Slashes PT On CEVA By 25%
  Raymond James boosted the price target on D.R. Horton, Inc. (NYSE: DHI) from $77 to $84. D.R. Horton shares rose 1.2% to $76.38 in pre-market trading. 
Via Benzinga
Snap, HCA Healthcare, Twitter And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Analyst Ratings For Surgery Partners
Over the past 3 months, 6 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022
Upgrades 
Via Benzinga
Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets. 
Via Benzinga
Airbnb And 3 Other Stocks Insiders Are Selling
Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s... 
Via Benzinga
HCA Healthcare's Softer Guidance Pulls Hospital Peers Down
Earlier today HCA Healthcare Inc (NYSE: HCA) reported Q1 earnings and cut FY22 guidance. The revised outlook is based on current expectations regarding the impact of the COVID-19 pandemic and related... 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
55 Biggest Movers From Friday
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate... 
Via Benzinga
Surgery Partners Stock Shows Market Leadership With Jump To 82 RS Rating
Surgery Partners sees its Relative Strength Rating move into the 80-plus level. 
Via Investor's Business Daily
Where Surgery Partners Stands With Analysts
Within the last quarter, Surgery Partners (NASDAQ:SGRY) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Surgery Partners: Q4 Earnings Insights
Surgery Partners (NASDAQ:SGRY) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Citigroup boosted the price target for Morgan Stanley (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ: 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.